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entheropathy, one a dyfunction of the systemic ventricle and edema, and the
last one severe venous insufficiency of the legs. A Melody valve was success-
fully inserted in all patients; three in the pathway, one after the iliac bifurca-
tion. There was no significant modification of the pressures after valvulation.
No acute complication was recorded. There was an improvement of the dop-
pler through the proclive and breathing. However, these were not associated
with significant clinical improvement. No thrombosis of the valve accured
during the short follow-up (1 to 6 months).
Conclusions: the valvulation of the Fontan circuit is easily performed. We
noticed an improvement of the hemodynamic and flow. However, no clinical
improvement was recorded as a result. A longer follow-up is needed to appre-
ciate the risks as well as the interest of this procedure.
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Background: percutaneous transcatheter heart valve replacement of aortic
or pulmonary valve is established. Transcatheter atrioventricular valve
replacement is been described. We report our experience focusing on the tech-
nical aspects.
Methods: we retrospectively review the files of patients who received a
transcatheter valve in tricuspid position between 2008 and 2012.
Results: Four patients were found. 3 had a heterograft (conduit of 14-mm,
Sorin 33 et Edwards Perimount 33) and one had a connection between the RA
and the RV infundibulum without a valve. Two patients had tricuspid regurgita-
tion as a primary lesion, one had stenotic valve and the last one a mixted lesion.
All successfully received a Melody valve from a femoral access. In patients with
stenotic lesion, a predilatation using a high pressure balloon was performed
before valve implant. In patients with regurgitation, the landing zone was cali-
brated using a low pressure balloon. These patients were presented to create a
landing zone of adequate diameter. Melody valves were inserted using a 22-mm
balloon catheter in 3 and a 24-mm in one. All but one were post-dilated. There
was no significant regurgitation. The mean gradient across the tricuspid valve
felt from 12 to 4.6-mmHg. One patient needed an epicardic pacemaker because
of AV block following balloon dilatation. One patient required inotropic support
and ventilation following the procedure but recovered after few days.
Conclusion: Transcatheter tricuspid valve insertion is feasible in patients
with surgical hetero or homografts after a careful selection. The mechanism of
dysfunction must be known. In case of stenosis or mixted lesions, the only
question is to know if the stenosis could be relief. In case of regurgitation, it
is very important to know the features of surgical substrats and to calibrate the
tricuspid orifice. Finally, patients with inappropriate landing zone should be
presented prior to valve insertion.
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Background: Idiopathic pulmonary arterial hypertension (IPAH) remains
a progressive fatal disease. Palliative Potts’shunt has been proposed in chil-
dren displaying supra-systemic IPAH.
Methods: A retrospective multicenter study to evaluate Potts’shunt in
pediatric IPAH.
Results: Between 2003 and 2010, 8 children with supra-systemic IPAH
and in WHO functional class IV despite medical PAH therapy underwent
Potts’shunt. Age at IPAH diagnosis ranged from 4 to 180 months (median
age: 64 months). Surgical procedure was performed in a mean delay of
41.9±54.3 months (from 4 to 167 months, median delay: 20 months) after
IPAH diagnosis. Mean size of the Potts’shunt was 9.25±3.30 mm. Two
patients, whose medical PAH therapy had been interrupted just after surgery,
died at post-operative day 11 and 13 from acute pulmonary hypertensive
crisis. After a mean follow-up of 63.7±16.1 months, the 6 children who were
discharged from hospital were alive. Functional status improved markedly in
the 6 survivors with a WHO functional class I (n=4) or II (n=2) at last follow-
up, consistent with significant improvement of 6 minute-walk distance
[302±95 (51±20% of theoretical values) vs 456±91 meters (68±10% of theo-
retical values), p=0.038] and decrease of brain natriuretic peptid (BNP) levels
(608±109 vs 76±45 pg/ml, p=0.035). No Potts’shunt was found restrictive at
last echocardiography.
Conclusion: Palliative Potts’shunt constitutes a new alternative to lung
transplantation in severely ill children with supra-systemic IPAH, carrying a
prolonged survival and persistent improvement in functional capacities.
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Conotruncal defects (CTD) are a group of cardiac malformations hetero-
geneous from an anatomic standpoint but with a common embryologic origin:
an abnormal rotation of the outflow tract. The outlet septum is therefore
malaligned or absent, resulting in a ventricular septal defect (VSD).
Aim of the study: To analyze the anatomy of the VSD in hearts with
CTD.
Material and methods: We reviewed 200 heart specimens with CTD from
the anatomic collection of the French Center of Reference for Complex
Congenital Heart Defects: 70 Tetralogy of Fallot (TOF), 53 TOF with pulmo-
nary atresia (TOF-PA), 54 common arterial trunk (CAT), and 23 interrupted
aortic arch type B (IAA-B). Special attention was paid to the rims of the VSD
viewed from the right ventricular side, the relationships between tricuspid and
aortic valves, and the anatomy of the outlet septum.
Results: The VSD was located between the 2 limbs of the septal band
(conoventricular) in all hearts. There was a fibrous continuity between tri-
cuspid and aortic valves in 0% of IAA-B, 66% of TOF, 37% of TOF-PA, 1%
of CAT (p<0.005). When present, this continuity always involved the anterior
tricuspid leaflet. The outlet septum was demonstrable in 81% of IAA-B, 96%
of TOF, 39% of TOF-PA, 0% of CAT (p<0.0001).
Conclusion: All CTD share the same VSD, located between the two limbs
of the septal band. However, there are some differences regarding the inferior
rim of the VSD. The continuity of the aortic valve with the anterior, and not
the septal, tricuspid leaflet indicates that this continuity may be a consequence
of the malposition of the ventriculo-infundibular fold, along with its outlet
septal component, rather than a perimembranous extension of the VSD.
Finally, these differences suggest an anatomic continuum from IAA-B to CAT
rather than distinct physiological phenotypes, related to various degrees of
abnormal rotation of the outflow tract, excessive in IAA-B, incomplete in
TOF, TOF-PA and CAT.
278
Congenital left coronary ostial atresia or stenosis – a series of four
neonatal fatal cases
Daniela Laux (1), Bettina Bessières (2), Fanny Bajolle (1), Younes
Boudjemline (1), Damien Bonnet (1)
(1) Hôpital ecker Enfants Malades, cardiologie pédiatrique, Paris,
France – (2) Hôpital ecker Enfants Malades, Unité de foetopathologie,
Service d’histo-embryologie et cytogénétique, Paris, France
© Elsevier Masson SAS. All rights reserved.
 
94 Archives of Cardiovascular Diseases Supplements (2013) 5, 90-101
Introduction: Congenital left coronary ostial atresia or severe stenosis is
an extremely rare coronary abnormality. The clinical picture is either cardiac
failure in the small infant or chest pain in the older child or adult patient. This
report describes four neonatal cases of this rare abnormality.
Methods: We retrospectively accessed all cases of left coronary ostial ste-
nosis or atresia seen in our center during an 11-year-period (2000 – 2011).
Two older patients with this diagnosis seen at 18 months and 4 years were
excluded from the study.
Results: Four neonates with the diagnosis of left coronary ostial atresia or
stenosis were identified during the study period. One newborn died within
minutes, the other within hours after birth because of cardiac failure refractory
to all treatment strategies. In both cases left coronary stenosis (one case with
a “pinpoint” orifice and the other with a “slitlike” orifice) was diagnosed at
autopsy. The third neonate was in cardiac failure due to a severe aortic ste-
nosis. Left coronary ostial atresia was diagnosed during emergency catheter
procedure. The infant subsequently died after the aortic dilatation. The forth
infant had a cardiac arrest at the third day of life after normal delivery and
neonatal adaptation. She was diagnosed with left coronary ostium atresia by
coronary angiography performed because of persistent biventricular dysfunc-
tion. She died during the attempt of revascularization surgery at 2 weeks of
life.
Conclusion: Congenital left coronary ostium atresia or stenosis is very
rare. Coronary angiography is the diagnostic method of choice especially in
the small child or infant. Revascularization surgery seems indicated in symp-
tomatic children based on case reports and smalls series. The clinical picture
described here for the first time in the neonate is dramatic and quickly fatal
with scarce surgical options. Systematic examination of the coronaries should
be part of any neonatal autopsy.
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Introduction: Transcatheter closure of ASD is now proposed as first line
treatment for the elderly patients.
Purpose: The aim of our study is to evaluating the transcatheter closure of
ASD in patients older than 60 years.
Methods:The records of 41 patients (37 women, 4 men) who are over 60
years (69.88±6 years, range 61-82 years), referred between April 1998 and
December 2010 for transcatheter closure of secundum ASD, were retrospec-
tively reviewed
Results: ASD was discovered during the assessment of patients with dys-
pnea (17) or arrhythmia (17). Average age at time of diagnosis was
62.4±14.89 years (range 14-82 years). 37.8% of cases had a delayed diagnosis.
At time of the procedure, 19 patients (46.3%) had supraventricular
arrhythmia and 82.9% of patients were dyspneic. Shunt ratio was 2.50±0.66,
defect size 19.67±6.76 mm, stretched diameter 24.36 mm±5.87, device dia-
meter of 24.49 mm±6.58. One patient was recused, because of increased left
atrial pressure at occlusion test.
Fluoroscopy time was 7.01±4.41 min.Success rate is 97.5%. Complete clo-
sure rate at one day and one month was 84.6% and 94.9% respectively. Sys-
tolic pulmonary pressure decreased from 49.37 to 34,58 mmHg at one month.
Hospital stay was 3.58 days ± 2.71.Periprocedural complication rate was
12.2%. 2 complications were major: one death by esophageal hematoma, and
one oropharyngeal bleeding, and 3 minors: 3 femoral arteriovenous fistulas.
At late follow-up (34±44 months, range 1month to 12 years), 34 patients
were in stage one, 4 recurred supraventricular arrhythmia, 1 needed pace
maker for sinus node dysfunction.
Conclusion: Transcatheter closure of ASD in ederly patients is effective.
It does not change rhythmic status but allows symptomatic improvement.
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Background: Pulmonary vasodilators in general and prostacyclin therapy
in particular have markedly improved the outcome of patients with pulmonary
arterial hypertension (PAH). Endothelial dysfunction is a key feature of PAH
and we previously described that circulating endothelial cells (CECs) could be
used as a biomarker of endothelial dysfunction in PAH. We now hypothesized
that PAH-specific vasodilator therapy might decrease CEC numbers.
Methods: We quantified CECs in peripheral blood from children with idio-
pathic PAH (iPAH, n =30) or PAH secondary to congenital heart disease (PAH-
CHD, n =30), before and after treatment and during follow up. CEC were enu-
merated by immunomagnetic separation with mAb CD146-coated beads.
Results: CEC counts were significantly decreased in children after treat-
ment with oral endothelin antagonists and/or PDE5 inhibitors. In 10 children
with refractory PAH despite combination oral therapies, SC treprostinil was
added and we found a further significant decrease in CEC count during the
first month of treatment in every patient. We quantified CEC during 6 to
36 months follow-up after initiation of SC treprostinil and found that CEC
count is modified according to clinical status.
Conclusions: CEC counts fall with vasodilatator therapy in PAH and could
also be used as biomarker of deterioration in refractory pediatric pulmonary
hypertension treated with SC treprostinil.
281
Use of covered stents for closure of fenestration in extracardiac
cavopulmonary connection: technical aspects and mid-term results
Sophie Guiti Malekzadeh Milani, Antoine Legendre, Damien Bonnet,
Younes Boudjemline
ecker EM, cardiologie pédiatrique, Paris, France
Objective: Closure of fenestration in a cavopulmonary connection (TCPC)
is performed with devices used to close intracardiac or aorto-pulmonary
connections. This study presents our data regarding the use of covered stents
in patients with fenestrated TCPC.
Methods: We retrospectively reviewed the data of all the patients receiving
a covered stent to close a fenestration of TCPC between 2005 and 2012.
Results: 38 patients were included. Mean age and weight were respectively
7.6 years and 20 kg. Femoral access was mainly used (32) but also jugular
access (5) and trans-hepatic access (1). A Cheatham Platinum Stent was used
(34) but we also used Atrium V12 Stents (4). The balloon size was chosen
according to the diameter of the conduit. We used BIB balloon (14) or simple
balloon (Tyshak or Balt) (16) (balloon not reported (4)). Mean procedural and
fluoroscopy times were respectively 42,5 +/ – 21 and 7,5±6,6 minutes. Mean
central venous pressure rose from 10 to 12mmHg. Mean oxygen saturation
increased from 90% to 96%. There was one anaphylactic shock at the end of the
procedure and one air embolisation without hemodynamic compromise. Full
occlusion was confirmed on angiogram in 36 patients. 2 cases required 2 stents
to achieve full occlusion. There was one minimal residual shunt and one failure
of the procedure with significant residual shunt in a patient with a conduit made
of a Gore-Tex patch between the atrium and the pulmonary arteries. There were
no embolic event, acute venous thrombosis or arrhythmias. Patients were treated
with anti vitamin K for 6 months then aspirin. Mean follow-up is 49 months
without thrombo-embolic complication or desaturation.
Conclusion: Covered stent is an option to close fenestration in extracardiac
TCPC. It is safe, easily achievable with low fluoroscopy time, very low risk
of thrombo-embolic events or failure. The good results are sustainable. The
main advantage of the technique is to avoid prosthetic device in the atrium
